2025-05-09 18:34:06, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_001134408 4745 bp mRNA linear PRI 15-JUL-2013 DEFINITION Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A), transcript variant 3, mRNA. ACCESSION NM_001134408 VERSION NM_001134408.1 GI:197313637 KEYWORDS RefSeq. SOURCE Homo sapiens (human) ORGANISM Homo sapiens Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo. REFERENCE 1 (bases 1 to 4745) AUTHORS Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S and Sullivan PF. CONSRTM Cross-Disorder Group of the Psychiatric Genomics Consortium TITLE Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis JOURNAL Lancet 381 (9875), 1371-1379 (2013) PUBMED 23453885 REMARK Erratum:[Lancet. 2013 Apr 20;381(9875):1360] REFERENCE 2 (bases 1 to 4745) AUTHORS Del-Aguila,J.L., Beitelshees,A.L., Cooper-Dehoff,R.M., Chapman,A.B., Gums,J.G., Bailey,K., Gong,Y., Turner,S.T., Johnson,J.A. and Boerwinkle,E. TITLE Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans JOURNAL Pharmacogenomics J. (2013) In press PUBMED 23400010 REMARK Publication Status: Available-Online prior to print REFERENCE 3 (bases 1 to 4745) AUTHORS Lieberman,R., Levine,E.S., Kranzler,H.R., Abreu,C. and Covault,J. TITLE Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro JOURNAL Alcohol. Clin. Exp. Res. 36 (10), 1678-1687 (2012) PUBMED 22486492 REMARK GeneRIF: After 7 days of chronic alcohol exposure there are significant increases in mRNA expression of GRIN2A in cultured neurons derived from alcoholic subjects, but not in cultures from nonalcoholics. REFERENCE 4 (bases 1 to 4745) AUTHORS Liu,L., Li,J., Yao,J., Yu,J., Zhang,J., Ning,Q., Wen,Z., Yang,D., He,Y., Kong,X., Song,Q., Chen,M., Yang,H., Liu,Q., Li,S. and Lin,J. TITLE A genome-wide association study with DNA pooling identifies the variant rs11866328 in the GRIN2A gene that affects disease progression of chronic HBV infection JOURNAL Viral Immunol. 24 (5), 397-402 (2011) PUBMED 22004137 REMARK GeneRIF: Polymorphism rs11866328 in the GRIN2A gene might be a genetic variant underlying the susceptibility of HBV carriers to disease progression. REFERENCE 5 (bases 1 to 4745) AUTHORS Tarabeux J, Kebir O, Gauthier J, Hamdan FF, Xiong L, Piton A, Spiegelman D, Henrion E, Millet B, Fathalli F, Joober R, Rapoport JL, DeLisi LE, Fombonne E, Mottron L, Forget-Dubois N, Boivin M, Michaud JL, Drapeau P, Lafreniere RG, Rouleau GA and Krebs MO. CONSRTM S2D team TITLE Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia JOURNAL Transl Psychiatry 1, E55 (2011) PUBMED 22833210 REMARK GeneRIF: Two de novo mutations in GRIN2A are identified in patients with sporadic schizophrenia. Publication Status: Online-Only REFERENCE 6 (bases 1 to 4745) AUTHORS Kornau,H.C., Schenker,L.T., Kennedy,M.B. and Seeburg,P.H. TITLE Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95 JOURNAL Science 269 (5231), 1737-1740 (1995) PUBMED 7569905 REFERENCE 7 (bases 1 to 4745) AUTHORS Magnuson,D.S., Knudsen,B.E., Geiger,J.D., Brownstone,R.M. and Nath,A. TITLE Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity JOURNAL Ann. Neurol. 37 (3), 373-380 (1995) PUBMED 7695237 REFERENCE 8 (bases 1 to 4745) AUTHORS Sakimura,K., Kutsuwada,T., Ito,I., Manabe,T., Takayama,C., Kushiya,E., Yagi,T., Aizawa,S., Inoue,Y., Sugiyama,H. et al. TITLE Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit JOURNAL Nature 373 (6510), 151-155 (1995) PUBMED 7816096 REFERENCE 9 (bases 1 to 4745) AUTHORS Sokolov,B.P. and Prockop,D.J. TITLE A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes JOURNAL Nucleic Acids Res. 22 (19), 4009-4015 (1994) PUBMED 7524031 REFERENCE 10 (bases 1 to 4745) AUTHORS Monyer,H., Sprengel,R., Schoepfer,R., Herb,A., Higuchi,M., Lomeli,H., Burnashev,N., Sakmann,B. and Seeburg,P.H. TITLE Heteromeric NMDA receptors: molecular and functional distinction of subtypes JOURNAL Science 256 (5060), 1217-1221 (1992) PUBMED 1350383 COMMENT REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from U90277.1, BC117131.1 and AK295620.1. Summary: N-methyl-D-aspartate (NMDA) receptors are a class of ionotropic glutamate-gated ion channels. These receptors have been shown to be involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. NMDA receptor channels are heteromers composed of the key receptor subunit NMDAR1 (GRIN1) and 1 or more of the 4 NMDAR2 subunits: NMDAR2A (GRIN2A), NMDAR2B (GRIN2B), NMDAR2C (GRIN2C) and NMDAR2D (GRIN2D). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]. Transcript Variant: This variant (3) is alternatively spliced at the 3' end compared to variant 1, resulting in a frame-shift and a shorter isoform (2) with a different C-terminus compared to isoform 1. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript exon combination :: BC143273.1 [ECO:0000332] RNAseq introns :: mixed/partial sample support ERS025082, ERS025083 [ECO:0000350] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end. PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-182 U90277.1 102-283 183-4319 BC117131.1 3-4139 4320-4745 AK295620.1 3752-4177 FEATURES Location/Qualifiers source 1..4745 /organism="Homo sapiens" /mol_type="mRNA" /db_xref="taxon:9606" /chromosome="16" /map="16p13.2" gene 1..4745 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="glutamate receptor, ionotropic, N-methyl D-aspartate 2A" /db_xref="GeneID:2903" /db_xref="HGNC:4585" /db_xref="MIM:138253" exon 1..191 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" misc_feature 126..128 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="upstream in-frame stop codon" exon 192..623 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" CDS 210..4055 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="isoform 2 precursor is encoded by transcript variant 3; N-methyl-D-aspartate receptor channel, subunit epsilon-1; glutamate [NMDA] receptor subunit epsilon-1; N-methyl-D-aspartate receptor subunit 2A; NMDA receptor subtype 2A; hNR2A; N-methyl D-aspartate receptor subtype 2A; glutamate receptor ionotropic, NMDA 2A" /codon_start=1 /product="glutamate receptor ionotropic, NMDA 2A isoform 2 precursor" /protein_id="NP_001127880.1" /db_xref="GI:197313638" /db_xref="CCDS:CCDS45407.1" /db_xref="GeneID:2903" /db_xref="HGNC:4585" /db_xref="MIM:138253" /translation="
MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHTFVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGYREFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLILSEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILTTAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPRLVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVEDIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLVTNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRSNGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVDQVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSLKTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALLQFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHLFYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRSAKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNMNELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDSIRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNHKTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVTLPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPHSETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGMTNAWLLGDAPRTLTNTRCHPRR
" sig_peptide 210..269 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" mat_peptide 270..4052 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /product="glutamate receptor ionotropic, NMDA 2A isoform 2" misc_feature 303..1385 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="N-terminal leucine/isoleucine/valine-binding protein (LIVBP)-like domain of the NR2 subunit of NMDA receptor family; Region: PBP1_iGluR_NMDA_NR2; cd06378" /db_xref="CDD:107373" misc_feature order(447..449,453..458,465..470,567..569,774..776, 783..785,825..827,831..833) /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="putative dimerization interface [polypeptide binding]; other site" /db_xref="CDD:107373" misc_feature 1581..>1850 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="Bacterial periplasmic transport systems use membrane-bound complexes and substrate-bound, membrane-associated, periplasmic binding proteins (PBPs) to transport a wide variety of substrates, such as, amino acids, peptides, sugars, vitamins and inorganic...; Region: PBPb; cd00134" /db_xref="CDD:29040" misc_feature 1740..1748 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q12879.1); Region: Glutamate binding (By similarity)" misc_feature 1875..2693 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="Ligand-gated ion channel; Region: Lig_chan; pfam00060" /db_xref="CDD:189368" misc_feature 1875..1937 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q12879.1); transmembrane region" misc_feature 2049..2051 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="non-experimental evidence, no additional details recorded" /note="Functional determinant of NMDA receptors (By similarity); propagated from UniProtKB/Swiss-Prot (Q12879.1); other site" misc_feature 2109..2171 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q12879.1); transmembrane region" misc_feature <2250..2597 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="Bacterial periplasmic transport systems use membrane-bound complexes and substrate-bound, membrane-associated, periplasmic binding proteins (PBPs) to transport a wide variety of substrates, such as, amino acids, peptides, sugars, vitamins and inorganic...; Region: PBPb; cd00134" /db_xref="CDD:29040" misc_feature 2274..2279 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q12879.1); Region: Glutamate binding (By similarity)" misc_feature order(2349..2351,2361..2363,2379..2381) /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="membrane-bound complex binding site; other site" /db_xref="CDD:29040" misc_feature 2478..2495 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="hinge residues; other site" /db_xref="CDD:29040" misc_feature 2658..2720 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="non-experimental evidence, no additional details recorded" /note="propagated from UniProtKB/Swiss-Prot (Q12879.1); transmembrane region" misc_feature 2724..>3983 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /note="N-methyl D-aspartate receptor 2B3 C-terminus; Region: NMDAR2_C; pfam10565" /db_xref="CDD:151103" variation 497 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="c" /replace="t" /db_xref="dbSNP:74853460" variation 606 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:77288930" exon 624..1216 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" variation 631 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="c" /replace="t" /db_xref="dbSNP:78631453" variation 1112 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="c" /replace="t" /db_xref="dbSNP:78241448" exon 1217..1331 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" variation 1278 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:78929970" variation 1314 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:77772378" exon 1332..1537 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" variation 1484 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:2229193" exon 1538..1706 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" exon 1707..1860 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" exon 1861..1986 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" exon 1987..2216 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" exon 2217..2377 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" variation 2233 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="c" /db_xref="dbSNP:75130648" exon 2378..2565 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" exon 2566..2804 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" exon 2805..3981 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" variation 2969 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:80138441" variation 3092 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="c" /replace="t" /db_xref="dbSNP:77705198" STS 3584..3719 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /standard_name="D16S2608E" /db_xref="UniSTS:151676" variation 3787 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="g" /replace="t" /db_xref="dbSNP:75761674" exon 3982..4735 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /inference="alignment:Splign:1.39.8" STS 3999..4223 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /standard_name="Grin2a" /db_xref="UniSTS:143261" variation 4025 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="t" /db_xref="dbSNP:78444267" variation 4071 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:74935155" variation 4173 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /replace="a" /replace="g" /db_xref="dbSNP:77029288" STS 4336..4569 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /standard_name="G10721" /db_xref="UniSTS:65875" STS 4544..4643 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /standard_name="D16S2596E" /db_xref="UniSTS:19233" STS 4567..4621 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" /standard_name="GRIN2A" /db_xref="UniSTS:480253" polyA_signal 4714..4719 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" polyA_site 4734 /gene="GRIN2A" /gene_synonym="EPND; GluN2A; NMDAR2A; NR2A" ORIGIN
agccctgctgcagagcctccggctgggatagccgccccccgtgggggcgatgcggacagcgcgggacagccaggggagcgcgctggggccgcagcatgcgggaacccgctaaacccggtggctgctgaggcggccgagatgctcgtgcgcgcagcgcgccccactgcatcctcgaccttctcgggctacagggaccgtcagtggcgactatgggcagagtgggctattggaccctgctggtgctgccggcccttctggtctggcgcggtccggcgccgagcgcggcggcggagaagggtccccccgcgctaaatattgcggtgatgctgggtcacagccacgacgtgacagagcgcgaacttcgaacactgtggggccccgagcaggcggcggggctgcccctggacgtgaacgtggtagctctgctgatgaaccgcaccgaccccaagagcctcatcacgcacgtgtgcgacctcatgtccggggcacgcatccacggcctcgtgtttggggacgacacggaccaggaggccgtagcccagatgctggattttatctcctcccacaccttcgtccccatcttgggcattcatgggggcgcatctatgatcatggctgacaaggatccgacgtctaccttcttccagtttggagcgtccatccagcagcaagccacggtcatgctgaagatcatgcaggattatgactggcatgtcttctccctggtgaccactatcttccctggctacagggaattcatcagcttcgtcaagaccacagtggacaacagctttgtgggctgggacatgcagaatgtgatcacactggacacttcctttgaggatgcaaagacacaagtccagctgaagaagatccactcttctgtcatcttgctctactgttccaaagacgaggctgttctcattctgagtgaggcccgctcccttggcctcaccgggtatgatttcttctggattgtccccagcttggtctctgggaacacggagctcatcccaaaagagtttccatcgggactcatttctgtctcctacgatgactgggactacagcctggaggcgagagtgagggacggcattggcatcctaaccaccgctgcatcttctatgctggagaagttctcctacatccccgaggccaaggccagctgctacgggcagatggagaggccagaggtcccgatgcacaccttgcacccatttatggtcaatgttacatgggatggcaaagacttatccttcactgaggaaggctaccaggtgcaccccaggctggtggtgattgtgctgaacaaagaccgggaatgggaaaaggtgggcaagtgggagaaccatacgctgagcctgaggcacgccgtgtggcccaggtacaagtccttctccgactgtgagccggatgacaaccatctcagcatcgtcaccctggaggaggccccattcgtcatcgtggaagacatagaccccctgaccgagacgtgtgtgaggaacaccgtgccatgtcggaagttcgtcaaaatcaacaattcaaccaatgaggggatgaatgtgaagaaatgctgcaaggggttctgcattgatattctgaagaagctttccagaactgtgaagtttacttacgacctctatctggtgaccaatgggaagcatggcaagaaagttaacaatgtgtggaatggaatgatcggtgaagtggtctatcaacgggcagtcatggcagttggctcgctcaccatcaatgaggaacgttctgaagtggtggacttctctgtgccctttgtggaaacgggaatcagtgtcatggtttcaagaagtaatggcaccgtctcaccttctgcttttctagaaccattcagcgcctctgtctgggtgatgatgtttgtgatgctgctcattgtttctgccatagctgtttttgtctttgaatacttcagccctgttggatacaacagaaacttagccaaagggaaagcaccccatgggccttcttttacaattggaaaagctatatggcttctttggggcctggtgttcaataactccgtgcctgtccagaatcctaaagggaccaccagcaagatcatggtatctgtatgggccttcttcgctgtcatattcctggctagctacacagccaatctggctgccttcatgatccaagaggaatttgtggaccaagtgaccggcctcagtgacaaaaagtttcagagacctcatgactattccccaccttttcgatttgggacagtgcctaatggaagcacggagagaaacattcggaataactatccctacatgcatcagtacatgaccaaatttaatcagaaaggagtagaggacgccttggtcagcctgaaaacggggaagctggacgctttcatctacgatgccgcagtcttgaattacaaggctgggagggatgaaggctgcaagctggtgaccatcgggagtgggtacatctttgccaccaccggttatggaattgcccttcagaaaggctctccttggaagaggcagatcgacctggccttgcttcagtttgtgggtgatggtgagatggaggagctggagaccctgtggctcactgggatctgccacaacgagaagaacgaggtgatgagcagccagctggacattgacaacatggcgggcgtattctacatgctggctgccgccatggcccttagcctcatcaccttcatctgggagcacctcttctactggaagctgcgcttctgtttcacgggcgtgtgctccgaccggcctgggttgctcttctccatcagcaggggcatctacagctgcattcatggagtgcacattgaagaaaagaagaagtctccagacttcaatctgacgggatcccagagcaacatgttaaaactcctccggtcagccaaaaacatttccagcatgtccaacatgaactcctcaagaatggactcacccaaaagagctgctgacttcatccaaagaggttccctcatcatggacatggtttcagataaggggaatttgatgtactcagacaacaggtcctttcaggggaaagagagcatttttggagacaacatgaacgaactccaaacatttgtggccaaccggcagaaggataacctcaataactatgtattccagggacaacatcctcttactctcaatgagtccaaccctaacacggtggaggtggccgtgagcacagaatccaaagcgaactctagaccccggcagctgtggaagaaatccgtggattccatacgccaggattcactatcccagaatccagtctcccagagggatgaggcaacagcagagaataggacccactccctaaagagccctaggtatcttccagaagagatggcccactctgacatttcagaaacgtcaaatcgggccacgtgccacagggaacctgacaacagtaagaaccacaaaaccaaggacaactttaaaaggtcagtggcctccaaataccccaaggactgtagtgaggtcgagcgcacctacctgaaaaccaaatcaagctcccctagagacaagatctacactatagatggtgagaaggagcctggtttccacttagatccaccccagtttgttgaaaatgtgaccctgcccgagaacgtggacttcccggacccctaccaggatcccagtgaaaacttccgcaagggggactccacgctgccaatgaaccggaaccccttgcataatgaagaggggctttccaacaacgaccagtataaactctactccaagcacttcaccttgaaagacaagggttccccgcacagtgagaccagcgagcgataccggcagaactccacgcactgcagaagctgcctttccaacatgcccacctattcaggccacttcaccatgaggtcccccttcaagtgcgatgcctgcctgcggatggggaacctctatgacatcgatgaagaccagatgcttcaggagacagggatgaccaacgcttggttattgggagatgcccctcggacccttacaaacactcgttgccatcccaggcggtgaatgacagctatcttcggtcgtccttgaggtcaacggcatcgtactgttccagggacagtcggggccacaatgatgtgtatatttcggagcatgttatgccttatgctgcaaataagaataatatgtactctacccccagggttttaaattcctgcagcaatagacgcgtgtacaagaaaatgcctagtatcgaatctgatgtttaaaaatcttccattaatgttttatctatagggaaatatacgtaatggccaatgttctggagggtaaatgttggatgtccaatagtgccctgctaagaggaagaagatgtagggaggtattttgttgttgttgttgttggctcttttgcacacggcttcatgccataatcttccactcaaggaatcttgtgaggtgtgtgctgagcatggcagacaccagataggtgagtccttaaccaaaaataactaactacataagggcaagtctccgggacatgcctactgggtatgttggcaataatgatgcattggatgccaatggtgatgttatgatttcctatattccaaattccattaaggtcagcccaccatgtaattttctcatcagaaatgcctaatggtttctctaatacagaataagcaatatggtgtgcatgtaaacctgacacagacaaaataaaaacagttaagaatgcaaaaaaaaaaa
//
ANNOTATIONS from NCBI Entrez Gene (20130726): GeneID:2903 -> Molecular function: GO:0004972 [N-methyl-D-aspartate selective glutamate receptor activity] evidence: IEA GeneID:2903 -> Molecular function: GO:0005234 [extracellular-glutamate-gated ion channel activity] evidence: IEA GeneID:2903 -> Molecular function: GO:0005262 [calcium channel activity] evidence: IEA GeneID:2903 -> Molecular function: GO:0005515 [protein binding] evidence: IPI GeneID:2903 -> Molecular function: GO:0008270 [zinc ion binding] evidence: ISS GeneID:2903 -> Biological process: GO:0001964 [startle response] evidence: IEA GeneID:2903 -> Biological process: GO:0001975 [response to amphetamine] evidence: IEA GeneID:2903 -> Biological process: GO:0006810 [transport] evidence: TAS GeneID:2903 -> Biological process: GO:0007215 [glutamate receptor signaling pathway] evidence: TAS GeneID:2903 -> Biological process: GO:0007268 [synaptic transmission] evidence: TAS GeneID:2903 -> Biological process: GO:0007611 [learning or memory] evidence: TAS GeneID:2903 -> Biological process: GO:0007613 [memory] evidence: IEA GeneID:2903 -> Biological process: GO:0008104 [protein localization] evidence: IEA GeneID:2903 -> Biological process: GO:0008542 [visual learning] evidence: IEA GeneID:2903 -> Biological process: GO:0009611 [response to wounding] evidence: IEA GeneID:2903 -> Biological process: GO:0019233 [sensory perception of pain] evidence: IEA GeneID:2903 -> Biological process: GO:0022008 [neurogenesis] evidence: IEA GeneID:2903 -> Biological process: GO:0030431 [sleep] evidence: IEA GeneID:2903 -> Biological process: GO:0033058 [directional locomotion] evidence: IEA GeneID:2903 -> Biological process: GO:0042177 [negative regulation of protein catabolic process] evidence: IEA GeneID:2903 -> Biological process: GO:0042417 [dopamine metabolic process] evidence: IEA GeneID:2903 -> Biological process: GO:0042428 [serotonin metabolic process] evidence: IEA GeneID:2903 -> Biological process: GO:0042493 [response to drug] evidence: IEA GeneID:2903 -> Biological process: GO:0043065 [positive regulation of apoptotic process] evidence: IEA GeneID:2903 -> Biological process: GO:0045471 [response to ethanol] evidence: IDA GeneID:2903 -> Biological process: GO:0048167 [regulation of synaptic plasticity] evidence: IEA GeneID:2903 -> Biological process: GO:0051930 [regulation of sensory perception of pain] evidence: IEA GeneID:2903 -> Biological process: GO:0060079 [regulation of excitatory postsynaptic membrane potential] evidence: IEA GeneID:2903 -> Cellular component: GO:0005886 [plasma membrane] evidence: TAS GeneID:2903 -> Cellular component: GO:0005887 [integral to plasma membrane] evidence: TAS GeneID:2903 -> Cellular component: GO:0008021 [synaptic vesicle] evidence: IEA GeneID:2903 -> Cellular component: GO:0009986 [cell surface] evidence: ISS GeneID:2903 -> Cellular component: GO:0014069 [postsynaptic density] evidence: IEA GeneID:2903 -> Cellular component: GO:0017146 [N-methyl-D-aspartate selective glutamate receptor complex] evidence: IDA GeneID:2903 -> Cellular component: GO:0030054 [cell junction] evidence: IEA GeneID:2903 -> Cellular component: GO:0042734 [presynaptic membrane] evidence: IEA GeneID:2903 -> Cellular component: GO:0043005 [neuron projection] evidence: IEA GeneID:2903 -> Cellular component: GO:0045211 [postsynaptic membrane] evidence: IEA
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.